ロード中...
217. Olanzapine Abolishes the Ability of Central Insulin to Inhibit Hepatic Glucose Production
Background: Atypical antipsychotics (AAPs), such as olanzapine (OLA), are widely prescribed but are associated with high rates of type 2 diabetes. Historically, the risk of diabetes was attributed to the weight gain propensity of AAPs; however, recent work shows that AAPs (a) can have immediate effe...
保存先:
| 出版年: | Schizophr Bull |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Oxford University Press
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5475754/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/schbul/sbx021.295 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|